

Drug group GW Pharmaceuticals has applied to the US Food & Drug Administration (FDA) for approval to test its Sativex product as a treatment for spast...


UK small caps rise 0.2 percent, while the blue chips climb 0.3 percent, and the midcaps are 0.1 percent higher. GW Pharmaceuticals adds 7.5 percent af...


AIM-listed biopharmaceutical company GW Pharmaceuticals has reported that the United States Patent and Trademark Office (USPTO) has issued a notice of...


* Germany refuses to pay "acceptable" price for Sativex * Almirall to challenge price decision, may withdraw supply * GW Pharmaceuticals aims to list ...


AIM-listed specialty pharmaceutical company GW Pharmaceuticals expects to account for a provision of 0.8m pounds in the financial year ending Septembe...


GW Pharmaceuticals, the British biotech firm, has seen clinical data released by partner Almirall that gives further backing for the efficacy of GW's ...


Clean energy products company Acta has announced the shipment of the first fully integrated fuel cell telecom back-up power system, incorporating Acta...


GW Pharmaceuticals has been given a lift after German authorities gave the thumbs up to its multiple sclerosis drug Sativex. The firm, and its partne...